Polydopamine-based “Four-In-One” versatile nanoplatforms for targeted dual chemo and photothermal synergistic cancer therapy

Gan Liu, Nansha Gao, Yun Zhou, Junpeng Nie, Wei Cheng, Miaomiao Luo, Lin Mei, Xiaowei Zeng, Wenbin Deng

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The development of versatile nanoscale drug delivery systems that integrate with multiple therapeutic agents or methods and improve the efficacy of cancer therapy is urgently required. To satisfy this demand, polydopamine (PDA)-modified polymeric nanoplatforms were constructed for the dual loading of chemotherapeutic drugs. The hydrophobic anticancer drug docetaxel (DTX) was loaded into the polymeric nanoparticles (NPs) which were fabricated from the star-shaped copolymer CA-PLGA. Then DTX-loaded NPs were coated with PDA, followed by conjugation of polyelethyl glycol (PEG)-modified targeting ligand aptamer AS1411(Apt) and adsorption of the hydrophilic anticancer drug doxorubicin (DOX). This “four-in-one” nanoplatform, referred to as DTX/NPs@PDA/DOX-PEG-Apt, demonstrated high near-infrared photothermal conversion efficiency and exhibited pH and thermo-responsive drug release behavior. Furthermore, it was able to specifically target MCF-7 human breast carcinoma cells and provide synergistic chemo-photothermal therapy to further improve the anticancer effect both in vitro and in vivo, providing a novel promising strategy for cancer therapy.

Original languageEnglish (US)
Article number507
JournalPharmaceutics
Volume11
Issue number10
DOIs
StatePublished - Oct 2019
Externally publishedYes

Fingerprint

docetaxel
Nanoparticles
Glycols
Doxorubicin
Neoplasms
Pharmaceutical Preparations
Therapeutics
Drug Delivery Systems
Adsorption
Breast Neoplasms
Ligands
polydopamine

Keywords

  • Aptamer
  • Dual drug delivery
  • Photothermal therapy
  • Polydopamine
  • Synergistic cancer therapy

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Polydopamine-based “Four-In-One” versatile nanoplatforms for targeted dual chemo and photothermal synergistic cancer therapy. / Liu, Gan; Gao, Nansha; Zhou, Yun; Nie, Junpeng; Cheng, Wei; Luo, Miaomiao; Mei, Lin; Zeng, Xiaowei; Deng, Wenbin.

In: Pharmaceutics, Vol. 11, No. 10, 507, 10.2019.

Research output: Contribution to journalArticle

Liu, Gan ; Gao, Nansha ; Zhou, Yun ; Nie, Junpeng ; Cheng, Wei ; Luo, Miaomiao ; Mei, Lin ; Zeng, Xiaowei ; Deng, Wenbin. / Polydopamine-based “Four-In-One” versatile nanoplatforms for targeted dual chemo and photothermal synergistic cancer therapy. In: Pharmaceutics. 2019 ; Vol. 11, No. 10.
@article{1be0dc7d848a422a987c55afbb0a6b33,
title = "Polydopamine-based “Four-In-One” versatile nanoplatforms for targeted dual chemo and photothermal synergistic cancer therapy",
abstract = "The development of versatile nanoscale drug delivery systems that integrate with multiple therapeutic agents or methods and improve the efficacy of cancer therapy is urgently required. To satisfy this demand, polydopamine (PDA)-modified polymeric nanoplatforms were constructed for the dual loading of chemotherapeutic drugs. The hydrophobic anticancer drug docetaxel (DTX) was loaded into the polymeric nanoparticles (NPs) which were fabricated from the star-shaped copolymer CA-PLGA. Then DTX-loaded NPs were coated with PDA, followed by conjugation of polyelethyl glycol (PEG)-modified targeting ligand aptamer AS1411(Apt) and adsorption of the hydrophilic anticancer drug doxorubicin (DOX). This “four-in-one” nanoplatform, referred to as DTX/NPs@PDA/DOX-PEG-Apt, demonstrated high near-infrared photothermal conversion efficiency and exhibited pH and thermo-responsive drug release behavior. Furthermore, it was able to specifically target MCF-7 human breast carcinoma cells and provide synergistic chemo-photothermal therapy to further improve the anticancer effect both in vitro and in vivo, providing a novel promising strategy for cancer therapy.",
keywords = "Aptamer, Dual drug delivery, Photothermal therapy, Polydopamine, Synergistic cancer therapy",
author = "Gan Liu and Nansha Gao and Yun Zhou and Junpeng Nie and Wei Cheng and Miaomiao Luo and Lin Mei and Xiaowei Zeng and Wenbin Deng",
year = "2019",
month = "10",
doi = "10.3390/pharmaceutics11100507",
language = "English (US)",
volume = "11",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Polydopamine-based “Four-In-One” versatile nanoplatforms for targeted dual chemo and photothermal synergistic cancer therapy

AU - Liu, Gan

AU - Gao, Nansha

AU - Zhou, Yun

AU - Nie, Junpeng

AU - Cheng, Wei

AU - Luo, Miaomiao

AU - Mei, Lin

AU - Zeng, Xiaowei

AU - Deng, Wenbin

PY - 2019/10

Y1 - 2019/10

N2 - The development of versatile nanoscale drug delivery systems that integrate with multiple therapeutic agents or methods and improve the efficacy of cancer therapy is urgently required. To satisfy this demand, polydopamine (PDA)-modified polymeric nanoplatforms were constructed for the dual loading of chemotherapeutic drugs. The hydrophobic anticancer drug docetaxel (DTX) was loaded into the polymeric nanoparticles (NPs) which were fabricated from the star-shaped copolymer CA-PLGA. Then DTX-loaded NPs were coated with PDA, followed by conjugation of polyelethyl glycol (PEG)-modified targeting ligand aptamer AS1411(Apt) and adsorption of the hydrophilic anticancer drug doxorubicin (DOX). This “four-in-one” nanoplatform, referred to as DTX/NPs@PDA/DOX-PEG-Apt, demonstrated high near-infrared photothermal conversion efficiency and exhibited pH and thermo-responsive drug release behavior. Furthermore, it was able to specifically target MCF-7 human breast carcinoma cells and provide synergistic chemo-photothermal therapy to further improve the anticancer effect both in vitro and in vivo, providing a novel promising strategy for cancer therapy.

AB - The development of versatile nanoscale drug delivery systems that integrate with multiple therapeutic agents or methods and improve the efficacy of cancer therapy is urgently required. To satisfy this demand, polydopamine (PDA)-modified polymeric nanoplatforms were constructed for the dual loading of chemotherapeutic drugs. The hydrophobic anticancer drug docetaxel (DTX) was loaded into the polymeric nanoparticles (NPs) which were fabricated from the star-shaped copolymer CA-PLGA. Then DTX-loaded NPs were coated with PDA, followed by conjugation of polyelethyl glycol (PEG)-modified targeting ligand aptamer AS1411(Apt) and adsorption of the hydrophilic anticancer drug doxorubicin (DOX). This “four-in-one” nanoplatform, referred to as DTX/NPs@PDA/DOX-PEG-Apt, demonstrated high near-infrared photothermal conversion efficiency and exhibited pH and thermo-responsive drug release behavior. Furthermore, it was able to specifically target MCF-7 human breast carcinoma cells and provide synergistic chemo-photothermal therapy to further improve the anticancer effect both in vitro and in vivo, providing a novel promising strategy for cancer therapy.

KW - Aptamer

KW - Dual drug delivery

KW - Photothermal therapy

KW - Polydopamine

KW - Synergistic cancer therapy

UR - http://www.scopus.com/inward/record.url?scp=85073477446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073477446&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics11100507

DO - 10.3390/pharmaceutics11100507

M3 - Article

AN - SCOPUS:85073477446

VL - 11

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 10

M1 - 507

ER -